Liver cancer and non-Hodgkin lymphoma in hepatitis C virus-infected patients: Results from the DANVIR cohort study
✍ Scribed by Lars Haukali Omland; Peter Jepsen; Henrik Krarup; Peer Brehm Christensen; Nina Weis; Lars Nielsen; Niels Obel; Henrik Toft Sørensen; Sherri Oliver Stuver; on behalf of the DANVIR cohort study
- Book ID
- 112101530
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- French
- Weight
- 1007 KB
- Volume
- 130
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Several studies have noted elevated hepatitis C virus (HCV) prevalence among patients with non‐Hodgkin lymphoma (NHL), suggesting that HCV infection increases NHL risk through chronic immune stimulation. Population‐based data from the U.S. are lacking. In a population‐based case‐control
The aim of this study was to evaluate the association between hepatitis C virus (HCV) infection and non-Hodgkin's lymphoma (NHL), multiple myeloma (MM), thyroid cancer (TC), chronic lymphatic leukemia (CLL), acute lymphatic leukemia (ALL), and Hodgkin's lymphoma (HL). A Swedish cohort of 27,150 HCV-